Integrin dysfunction key finding to implantation failure

Integrin dysfunction has emerged as a significant contributor to implantation failure and reproductive disorders, prompting extensive research efforts to elucidate its role in reproductive biology. Integrins, a family of cell adhesion molecules, play crucial roles in mediating embryo-endometrial interactions during implantation. Dysregulated integrin expression or function in the endometrium or the embryo can impair the establishment of pregnancy, leading to recurrent implantation failure and infertility. This paper provides a comprehensive overview of integrin dysfunction and its connection to implantation failure, highlighting key findings regarding integrin expression patterns, mechanisms of dysfunction, clinical implications, and future directions. Through integrative approaches combining omics-based profiling, bioinformatics analysis, and experimental validation, researchers have identified novel integrin isoforms and regulatory elements involved in implantation. Furthermore, therapeutic strategies targeting integrins offer promising avenues for improving implantation success and fertility outcomes in patients undergoing assisted reproductive technologies. However, further research is warranted to deepen our understanding of integrin-related issues in reproductive medicine and develop personalized interventions for patients with implantation disorders. By bridging the gap between basic research and clinical practice, advancements in integrin research hold the potential to enhance fertility outcomes and fulfil the aspirations of individuals seeking to build their families.